Home    Back

Azm    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
228Bronchiolitis obliterans1

228. Bronchiolitis obliterans    [ 92 clinical trials,   125 drugs,   (DrugBank: 34 drugs),   33 drug target genes,   152 drug target pathways]
Searched query = "Bronchiolitis obliterans", "Obliterating bronchiolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 92 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02543073
(ClinicalTrials.gov)		September 20144/9/2015MSC for Treatment of Interstitial Lung Disease After Allo-HSCTMesenchymal Stem Cell for Treatment of Interstitial Lung Disease After Allogenetic Hematopoietic Stem Cell TransplantationLung Diseases, Interstitial;Hematopoietic Stem Cell Transplantation;Bronchiolitis ObliteransBiological: MSCs;Drug: AZM;Drug: GlucocorticoidNanfang Hospital of Southern Medical UniversitySun Yat-sen UniversityRecruiting18 Years65 YearsAll60Phase 1;Phase 2China